Viatris, Inc. (VTRS)
20.84
+0.17
(+0.82%)
USD |
NASDAQ |
Nov 13, 16:00
20.75
-0.09
(-0.43%)
After-Hours: 19:59
Viatris Shareholders Equity (Quarterly) : 13.69B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 13.69B |
| June 30, 2026 | 14.26B |
| March 31, 2026 | 14.66B |
| December 31, 2025 | 14.71B |
| September 30, 2025 | 15.22B |
| June 30, 2025 | 15.57B |
| March 31, 2025 | 15.65B |
| December 31, 2024 | 18.64B |
| September 30, 2024 | 19.79B |
| June 30, 2024 | 19.52B |
| March 31, 2024 | 20.01B |
| December 31, 2023 | 20.47B |
| September 30, 2023 | 20.87B |
| June 30, 2023 | 20.84B |
| March 31, 2023 | 20.93B |
| December 31, 2022 | 21.07B |
| September 30, 2022 | 19.18B |
| June 30, 2022 | 19.81B |
| March 31, 2022 | 20.45B |
| December 31, 2021 | 20.49B |
| September 30, 2021 | 21.14B |
| June 30, 2021 | 21.21B |
| March 31, 2021 | 21.41B |
| December 31, 2020 | 22.95B |
| September 30, 2020 | 12.55B |
| Date | Value |
|---|---|
| June 30, 2020 | 11.75B |
| March 31, 2020 | 11.26B |
| December 31, 2019 | 11.88B |
| September 30, 2019 | 11.46B |
| June 30, 2019 | 11.90B |
| March 31, 2019 | 11.89B |
| December 31, 2018 | 12.17B |
| September 30, 2018 | 12.07B |
| June 30, 2018 | 12.21B |
| March 31, 2018 | 13.18B |
| December 31, 2017 | 13.31B |
| September 30, 2017 | 13.29B |
| June 30, 2017 | 12.83B |
| March 31, 2017 | 11.66B |
| December 31, 2016 | 11.12B |
| September 30, 2016 | 11.83B |
| June 30, 2016 | 10.33B |
| March 31, 2016 | 10.27B |
| December 31, 2015 | 9.764B |
| September 30, 2015 | 9.814B |
| June 30, 2015 | 9.568B |
| March 31, 2015 | 9.073B |
| December 31, 2014 | 3.256B |
| September 30, 2014 | 3.388B |
| June 30, 2014 | 3.334B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pacira Biosciences, Inc. | 712.32M |
| Pfizer Inc. | 89.00B |
| Eli Lilly & Co. | 40.27B |
| Merck & Co., Inc. | 44.89B |
| Amphastar Pharmaceuticals, Inc. | 814.55M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.68B |
| Total Liabilities (Quarterly) | 21.00B |
| Debt to Equity Ratio | 0.9924 |
| Current Ratio | 1.459 |
| Net Debt Paydown Yield | 1.17% |